|
[1]MASARONE M, FEDERICO A, ABENAVOLI L, et al.Non alcoholic Fatty liver:epidemiology and natural history[J].Rev Recent Clin Trials, 2014, 9 (3) :126-133.
|
|
[2]Branch of Gastrointestinal Diseases, China Association of Chinese Medicine.Common understanding on Chinese medicine diagnosis and treatment of nonalcoholic fatty liver disease[J].Beijing J Tradit Chin Med, 2011, 30 (2) :83-86. (in Chinese) 中华中医药学会脾胃病分会.非酒精性脂肪性肝病中医诊疗共识意见[J].北京中医药, 2011, 30 (2) :83-86.
|
|
[3]LI JX, CHEN RH, SU DM, et al.Advances in management of nonalcoholic fatty liver disease by Chinese medicine[J].World Chin J Dig, 2010, 18 (14) :1443-1451. (in Chinese) 李军祥, 陈润花, 苏冬梅, 等.中医药治疗非酒精性脂肪性肝病研究述评[J].世界华人消化杂志, 2010, 18 (14) :1443-1451.
|
|
[4]ZHANG SS, WANG CJ, SHEN H.Practical guide for special medical subjects:digestive diseases (1st edition) [M].Beijing:China Press of Traditional Chinese Medicine, 2008:214-221. (in Chinese) 张声生, 王垂杰, 沈洪.特色专科实用手册·消化病 (第1版) [M].北京:中国中医药出版社, 2008:214-221.
|
|
[5]JI G, ZHENG PY.Research review of traditional Chinese medicine treatment of fatty liver disease[J].Chin Arch Tradit Chin Med, 2004, 22 (1) :87-90. (in Chinese) 季光, 郑培永.中医药治疗脂肪肝的研究述评[J].中医药学刊, 2004, 22 (1) :87-90.
|
|
[6]LI YH, ZHANG BL, XU ZP, et al.Systematical review on treating fatty liver with TCM by differentiation of symptom[J].Liaoning JTradit Chin Med, 2002, 29 (11) :657-658. (in Chinese) 李玉红, 张伯礼, 徐宗佩, 等.脂肪肝中医药辨治系统评价[J].辽宁中医杂志, 2002, 29 (11) :657-658.
|
|
[7]SPENGLER EK, LOOMBA R.Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J].Mayo Clin Proc, 2015, 90 (9) :1233-1246.
|
|
[8]ARIENTI V, ALUIGI L, PRETOLANI S, et al.Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage.Possible application in a population study on the metabolic syndrome (MS) [J].Intern Emerg Med, 2012, 7 (3) :283-290.
|
|
[9]LDINGHEN VD, WONG GL, VERGNIOL J, et al.Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease[J].J Gastroenterol Hepatol, 2016, 31 (4) :848-855.
|
|
[10]GRAFFY PM, PICKHARDT PJ.Quantification of hepatic and visceral fat by CT and MR imaging:relevance to the obesity epidemic, metabolic syndrome and NAFLD[J].Br J Radiol, 2016, 89 (1062) :20151024.
|
|
[11]HAN MA, SAOUAF R, AYOUB W, et al.Magnetic resonance imaging and transient elastography in the management of nonalcoholic fatty liver disease (NAFLD) [J].Expert Rev Clin Pharmacol, 2017, 10 (4) :379-390.
|
|
[12]Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.
|
|
[13]QIAN Y.“Simultaneous regulation of the liver and its function”is an important link in treatment of severe chronic hepatitis[J].Chin JIntegr Tradit West Med Liver Dis, 2006, 16 (4) :251-252. (in Chinese) 钱英.“体用同调”是治疗慢性重型肝炎的重要一环[J].中西医结合肝病杂志, 2006, 16 (4) :251-252.
|
PDF下载 ( 224 KB)
本文二维码
下载:
